PetMed Express (PETS)
(Delayed Data from NSDQ)
$3.28 USD
-0.01 (-0.30%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $3.28 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$3.28 USD
-0.01 (-0.30%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $3.28 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth F Momentum B VGM
Zacks News
5 Consumer Stocks to Yield Returns Despite US-China Tensions
by Zacks Equity Research
Although the ongoing trade dispute between the United States and China can take a toll on sectors that are cyclical in nature, a few stocks promise stellar returns in 2018.
Alphabet Boosts Self-Driving Cars With Waymo-Jaguar Deal
by Zacks Equity Research
Alphabet's (GOOGL) self-driving car unit, Waymo, partners with Jaguar, expanding its self-driving car fleet.
Amazon Green Lights Cortes Series, Lifts Digital Media Sales
by Zacks Equity Research
Amazon.com (AMZN) is constantly expanding its video content and increasing Prime members to further penetrate the streaming market.
Baidu (BIDU) Announces Notes Offering Worth $1.5 Billion
by Zacks Equity Research
Baidu, Inc. (BIDU) announced a public offering of notes aggregating $1.5 billion. The move will help the company bring down its cost of capital, thereby strengthening its balance sheet.
Amazon Teams Up With Monoprix, Bolsters Presence in Europe
by Zacks Equity Research
Amazon's (AMZN) new partnership with Monoprix will allow the prime members to shop the grocer's products online via Prime Now app.
4 Stocks to Yield Better Returns as Retail Sales Pick Up
by Zacks Equity Research
In an evolving retail space characterized by increased consumer demand, four stocks are expected to record significant earnings growth in 2018.
Wayfair (W) Opens New Service Center, Adds 450 Jobs in NY
by Zacks Equity Research
Wayfair (W) opens a new customer service center in New York to expand its operations and enhance distribution services.
Bear of the Day: Overstock.com (OSTK)
by Brian Hamilton
Increased competition put significant pressure on its earnings results.
KLA-Tencor to Buy Orbotech, Announces $2B Buyback Program
by Zacks Equity Research
KLA-Tencor (KLAC) announces to acquire Orbotech (ORBK) in a bid to diversify its revenue base.
Semtech's (SMTC) Q4 Earnings Beat Estimates, View Strong
by Zacks Equity Research
Semtech's (SMTC) fiscal fourth-quarter 2018 earnings beat on differentiated growth drivers and diversification strategy.
Top Ranked Growth Stocks to Buy for March 19th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, March 19th:
Analog (ADI) Buys Symeo, Boosts Radar Technology Offerings
by Zacks Equity Research
Analog Devices (ADI) recently acquires Symeo GmbH to bolster its offerings in radar technology.
Analog Devices Prices Senior Notes, Gets Moody's Baa1 Rating
by Zacks Equity Research
Analog Devices (ADI) prices an offering of $750 million of senior unsecured notes.
Amazon to Expand in India by Adding Original Regional Content
by Zacks Equity Research
Amazon.com (AMZN) is planning to expand its original regional content that will strengthen competitive position in Indian streaming market.
Cooper Companies (COO) Tops Q1 Earnings & Revenue Estimates
by Zacks Equity Research
Cooper Companies (COO) Q1 results gain from strength in CooperVision segment.
Genomic Health (GHDX) Q4 Earnings & Revenues Miss Estimates
by Zacks Equity Research
Genomic Health's (GHDX) escalating operating expenses dent bottom line in Q4.
Market Rally Boosts Household Net Worth: 5 Top-Ranked Picks
by Nalak Das
Substantial increase in wealth could make many Americans more confident and lead them to spend more fueling economic growth.
Amazon Roundup: Streams Music in India, Buys Ring
by Sejuti Banerjea
Amazon (AMZN) has launched Prime Music in the crowded Indian music streaming market and also picked up smart doorbell maker Ring for a billion dollars.
Orthofix PhysioStim's FDA Nod and CE Mark Boosts Prospects
by Zacks Equity Research
Orthofix (OFIX) vouches for PhysioStim's efficiency, claiming the devices to lead the U.S. market of prescribed bone growth stimulators combined with spinal fusion stimulators.
Quest Diagnostics Long-Term View Solid, Reimbursement a Woe
by Zacks Equity Research
Quest Diagnostics' (DGX) upgraded long-term guidance based on its new and extended two-point strategy looks promising. However, it expresses resentment against the recent PAMA-related CMS proposal.
Veeva Systems Vault Clinical Platform to Aid Ora's Operations
by Zacks Equity Research
Veeva Systems' (VEEV) Vault Clinical Suite to be incorporated into Ora's system for improved patient outcome.
Haemonetics (HAE) Hits a 52-Week High: What's Driving It?
by Zacks Equity Research
Haemonetics (HAE) upbeat on integration of NexSys PCS device. A raised EPS guidance buoys optimism.
CryoLife (CRY) Beats Earnings and Revenue Estimates in Q4
by Zacks Equity Research
CryoLife (CRY) gains on growth in all the product lines along with a strong performance in all the geographies in Q4.
Falling Earnings Estimates Signal Weakness Ahead for Expedia (EXPE)
by Zacks Equity Research
Expedia (EXPE) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
NuVasive Gains From International Business Amid Pricing Woes
by Zacks Equity Research
Sturdy performance of NuVasive's (NUVA) international business with more than 20% growth for the fifth consecutive quarter raises optimism among investors